Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $791.00 | 7 | 86.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $124.65 | 1 | 13.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb Americas Inc. | $249.62 | 2 | $0 (2023) |
| Horizon Therapeutics plc | $240.25 | 2 | $0 (2022) |
| Kala Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2021) |
| Glaukos Corporation | $118.77 | 1 | $0 (2023) |
| Shire North American Group Inc | $98.28 | 1 | $0 (2018) |
| NEW WORLD MEDICAL,INC. | $83.73 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $327.47 | 3 | Bausch & Lomb Americas Inc. ($124.97) |
| 2022 | $245.54 | 2 | Bausch & Lomb Americas Inc. ($124.65) |
| 2021 | $244.36 | 2 | Kala Pharmaceuticals, Inc. ($125.00) |
| 2018 | $98.28 | 1 | Shire North American Group Inc ($98.28) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Ophthalmology | ||||||
| 06/22/2023 | NEW WORLD MEDICAL,INC. | — | Food and Beverage | In-kind items and services | $83.73 | General |
| 05/04/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $118.77 | General |
| 11/17/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $120.89 | General |
| Category: TEPEZZA | ||||||
| 08/25/2022 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $124.65 | General |
| Category: Ophthalmology | ||||||
| 11/18/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $119.36 | General |
| Category: TEPEZZA | ||||||
| 08/19/2021 | Kala Pharmaceuticals, Inc. | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ocular | ||||||
| 06/14/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $98.28 | General |
| Category: OPTHALMICS | ||||||
About Dr. Gerald Mayer, OD
Dr. Gerald Mayer, OD is a Optometrist healthcare provider based in Lauderhill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184658270.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerald Mayer, OD has received a total of $915.65 in payments from pharmaceutical and medical device companies, with $327.47 received in 2023. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($791.00).
Practice Information
- Specialty Optometrist
- Location Lauderhill, FL
- Active Since 07/11/2006
- Last Updated 04/17/2012
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184658270
Products in Payments
- TEPEZZA (Drug) $240.25
- EYSUVIS (Drug) $125.00
- MIEBO (Drug) $124.97
- INFUSE (Device) $124.65
- XIIDRA (Drug) $98.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.